🇺🇸 FDA
Patent

US 12012454

Anti-tumor antigen nanobody and nucleic acid encoding sequence thereof, and uses of the same

granted A61PA61P35/00

Quick answer

US patent 12012454 (Anti-tumor antigen nanobody and nucleic acid encoding sequence thereof, and uses of the same) held by China Medical University Hospital expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University Hospital
Grant date
Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00